Align Technology | ALGN - Zinsaufwendungen Für Schuld

Aktienkurs
189.39
Täglich Wechseln
-0.22 -0.12%
Monatlich
13.91%
Jährlich
4.58%
Q2 Prognose
185.55




Zinsaufwendungen Für Schuld Veränderung Datum
3M USD 214M 18M 2026-03
Align Technology USD 2M 660K 2023-03
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bruker USD 20M 4.3M 2025-09
Cardinal Health USD 88M 8M 2025-12
Charles River Laboratories USD 23.78M 1.63M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
CVS Health USD 787M 3M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
Dexcom USD 4.7M 0 2025-09
Henry Schein USD 39M 1000K 2025-12
Idexx Laboratories USD 10.08M 1.24M 2025-09
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
IQVIA Holdings USD 193M 4M 2025-12
Masimo USD 7.5M 1.3M 2025-12
McKesson USD 63M 11M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Revvity USD 23.51M 742K 2025-12
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Teleflex USD 28.15M 3.69M 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Veeva Systems USD 65.1M 8.4M 2025-03
Waters USD 8.62M 18.02M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12
Zoetis USD 57M 1000K 2025-12